ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

BIOP Bioptix

7.67
0.00 (0.00%)
Pre Market
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Bioptix NASDAQ:BIOP NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 7.67 7.50 7.80 0 01:00:00

APPY SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Class Action Against Venaxis, Inc. and Its Board of Direc...

03/03/2015 6:19pm

PR Newswire (US)


Bioptix, Inc. (NASDAQ:BIOP)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Bioptix, Inc. Charts.

NEW YORK, March 3, 2015 /PRNewswire/ -- Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of Colorado on behalf of investors who purchased Venaxis, Inc. ("Venaxis" or the "Company") (NasdaqCM: APPY) securities between March 13, 2014 and January 28, 2015.

Levi & Korsinsky, LLP

To get more information, click here: http://zlk.9nl.com/venaxis-appy. There is no cost or obligation to you.

The complaint stems from the Company's January 29, 2015 disclosure that the FDA determined that the APPY1 Test, designed to aid in the identification of patients at low risk for acute appendicitis, "did not meet the criteria for substantial equivalence based on the data and information submitted by the company in its 510(k) submission." The disclosure followed months of positive statements by the Company regarding the APPY1 Test.

If you suffered a loss in Venaxis you have until April 3, 2015 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. To obtain additional information, contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/venaxis-appy.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:   
Levi & Korsinsky, LLP
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004           
Tel: (212) 363-7500
Toll Free:  (877) 363-5972
Fax: (866) 367-6510
www.zlk.com

Logo - http://photos.prnewswire.com/prnh/20120409/MM84375LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/appy-shareholder-alert-levi--korsinsky-llp-notifies-investors-of-class-action-against-venaxis-inc-and-its-board-of-directors-and-a-lead-plaintiff-deadline-of-april-3-2015--appy-300044742.html

SOURCE Levi & Korsinsky, LLP

Copyright 2015 PR Newswire

1 Year Bioptix, Inc. Chart

1 Year Bioptix, Inc. Chart

1 Month Bioptix, Inc. Chart

1 Month Bioptix, Inc. Chart

Your Recent History

Delayed Upgrade Clock